Vetsys Pharmaceutical
Vetsys Pharmaceutical
Premium ectoparasite and endoparasite pour-on treatments manufactured under strict GMP compliance, engineered to resist heavy rainfall and tropical humidity.
The Republic of Kiribati, an archipelagic nation composed of 33 low-lying coral atolls and reef islands in the central Pacific, presents highly distinct ecological and logistical conditions. The agricultural economy relies heavily on smallholder swine and poultry farming. Due to the high salinity, sandy soils, and lack of freshwater aquifers, traditional dipping or high-volume spraying of livestock with antiparasitic agents poses a direct threat to the fragile subterranean lens aquifers. Groundwater contamination is a key risk factor monitored by local environmental and biosecurity offices.
Furthermore, the hot, humid equatorial climate is highly favorable for the rapid proliferation of ectoparasites, particularly sarcoptic mange mites, lice, and ticks. In this environment, conventional treatment methods such as intramuscular injections require intensive labor, carry high risks of secondary microbial infections at the injection site due to high humidity, and cause considerable animal stress. Consequently, specialized, low-dose, high-concentration transdermal (pour-on) solutions are increasingly critical for biosecurity and livestock health management in the Pacific region.
Globally, the veterinary pharmaceutical industry is moving away from invasive systemic drug deliveries in favor of localized transdermal absorption systems. Pour-on formulas leverage advanced chemical carriers, such as isopropyl myristate or pyrrolidone-based solvents, which temporarily alter the lipid structure of the stratum corneum. This allows the active ingredients (such as Avermectin, Ivermectin, or Eprinomectin) to penetrate the skin and accumulate in the subcutaneous tissues and sebaceous glands, creating a long-acting depot effect. This mechanism ensures sustained therapeutic blood plasma levels, controlling both internal roundworms and external biting parasites over extended cycles.
Producing pour-on solutions for tropical applications requires balancing rainfastness, UV stability, and skin permeability. The high ultraviolet exposure in Kiribati accelerates the photodegradation of avermectins. To mitigate this, Vetsys formulations incorporate specialized photoprotective lipid barriers and antioxidants. Furthermore, the viscosity is optimized to ensure that the fluid spreads rapidly across the sebum layer of the animal's backline without running off or crystallizing on the hair shaft, guaranteeing a highly predictable pharmacokinetic profile.
Established in 2005, Zhengzhou Vetsys Pharmaceutical Co., Ltd. (Vetsys) is a leading manufacturer in the animal pharmaceutical industry. With a registered capital of 30 million RMB, our modern facility includes specialized GMP-compliant workshops for producing a comprehensive array of animal health products, including powders, premixes, injections, powder injections, oral solutions, tablets, granules, herbal extracts, and disinfectants.
Our commitment to excellence is backed by an independent research institute with five specialized laboratories and a world-class team of scientists. This research core enables us to adapt quickly to changing market demands, formulating solutions targeted to specific regional environments like the Pacific Islands.
Partner With Us
Vetsys operates under strict international GMP guidelines, utilizing advanced molding, extrusion, assembly, and drying technology to construct high-barrier containers that preserve chemical stability during maritime shipping.
Explore our highly requested range of anti-parasitic solutions, broad-spectrum oral therapies, and concentrated insecticidal formulas.
Complementary industrial raw materials, structural compounds, and lubricants customized for coastal transport networks and Pacific logistics hubs.
Aligning pharmacological innovation with environmental sustainability to support food security across the South Pacific.
Transitioning carrier systems from petroleum-based hydrocarbons to organic, plant-derived esters to eliminate long-term ecotoxicological risks to marine life and groundwaters.
Developing hydrophobic resin binders that keep the active drug adhered to the hair follicle during heavy monsoonal storms, minimizing wastage and ensuring consistent therapeutic dosing.
Refining transdermal molecular weights to optimize systemic absorption times, reducing systemic irritation and minimizing residue levels in consumer-facing meat products.
Key information regarding importation, chemical stability, and administration of pour-on solutions in tropical island environments.
Speak directly with our technical sourcing team. Get custom formulation parameters, shipping timelines to South Pacific ports, and volume-based pricing structures.
Send Inquiry Now